SL
TNDM icon

Salomon & Ludwin’s Tandem Diabetes Care TNDM Stock Holding History

Salomon & Ludwin’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.37K Sell
595
-181
-23% -$3.16K ﹤0.01% 1616
2026
Q1 		$14.4K Buy
776
+181
+30% +$3.93K ﹤0.01% 1311
2025
Q4 		$13.8K Sell
595
-9
-1% -$162 ﹤0.01% 1199
2025
Q3 		$8.88K Buy
+604
New +$8.18K ﹤0.01% 1403

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Salomon & Ludwin's TNDM Position: Q2 2026 in Review

Salomon & Ludwin reduced its Tandem Diabetes Care (TNDM) stake by 23% in Q2 2026, selling an estimated $3.16K and leaving 595 shares worth $9.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1616.

Salomon & Ludwin first reported a position in TNDM in Q3 2025 and has held it in 4 quarters since. The position peaked at $14.4K in Q1 2026. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Salomon & Ludwin held 595 shares of Tandem Diabetes Care worth $9.37K as of Q2 2026.
  • Salomon & Ludwin sold 181 Tandem Diabetes Care shares in Q2 2026, an estimated $3.16K.
  • Tandem Diabetes Care made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1616 holding.
  • Salomon & Ludwin first reported a position in Tandem Diabetes Care in Q3 2025 and has held it in 4 quarters since.
  • Salomon & Ludwin's Tandem Diabetes Care position peaked at $14.4K in Q1 2026.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.